| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1817 | 2023 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 1215 | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 635 | 2022 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 469 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 449 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 418 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 288 | 2024 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 WM Gardner, C Razo, TA McHugh, H Hagins, VM Vilchis-Tella, ... The Lancet Haematology 10 (9), e713-e734, 2023 | 224 | 2023 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 178 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet Infectious Diseases 22 (11), 1626-1647, 2022 | 169 | 2022 |
| The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis B Sartorius, AP Gray, ND Weaver, GR Aguilar, LR Swetschinski, KS Ikuta, ... The Lancet Global Health 12 (2), e201-e216, 2024 | 103 | 2024 |
| The effect of climate change and the snail-schistosome cycle in transmission and bio-control of schistosomiasis in Sub-Saharan Africa TA Adekiya, RT Aruleba, BE Oyinloye, KO Okosun, AP Kappo International journal of environmental research and public health 17 (1), 181, 2020 | 101 | 2020 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 88 | 2024 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 71 | 2023 |
| Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer RT Aruleba, TA Adekiya, BE Oyinloye, AP Kappo International journal of molecular sciences 19 (2), 386, 2018 | 65 | 2018 |
| The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: A systematic analysis for the global burden of disease … AR Da Cunha, K Compton, R Xu, R Mishra, MT Drangsholt, JLF Antunes, ... JAMA oncology 9 (10), 1401-1416, 2023 | 60 | 2023 |
| COVID-19 diagnosis: A review of rapid antigen, RT-PCR and artificial intelligence methods RT Aruleba, TA Adekiya, N Ayawei, G Obaido, K Aruleba, ID Mienye, ... Bioengineering 9 (4), 153, 2022 | 45 | 2022 |
| PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs? RT Aruleba, TA Adekiya, BE Oyinloye, P Masamba, LS Mbatha, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2019 | 42 | 2019 |
| Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach AO Fadaka, RT Aruleba, NRS Sibuyi, A Klein, AM Madiehe, M Meyer Journal of Biomolecular Structure and Dynamics 40 (8), 3416-3427, 2022 | 41 | 2022 |
| Applications of computational methods in biomedical breast cancer imaging diagnostics: a review K Aruleba, G Obaido, B Ogbuokiri, AO Fadaka, A Klein, TA Adekiya, ... Journal of Imaging 6 (10), 105, 2020 | 39 | 2020 |
Tayo Alex Adekiya, Ph.DHoward UniversityEmail yang diverifikasi di howard.edu
